描述
Winolap 5 ml Eye Drops (Olopatadine Hydrochloride Ophthalmic Solution 0.1% w/v) is a high-efficacy, dual-action therapeutic formulation manufactured by Sun Pharmaceutical Industries Ltd. Designed for the symptomatic relief of seasonal allergic conjunctivitis, Winolap combines the rapid action of a selective H1-receptor antagonist with the long-term stability of a mast cell stabilizer. It is globally recognized as a premier clinical equivalent to innovator brands, providing targeted relief from ocular itching, redness, and swelling.
1. Manufacturer Profile: Sun Pharmaceutical Industries Ltd
Sun Pharma is the world’s fourth-largest specialty generic pharmaceutical company, renowned for its commitment to high-quality ophthalmic delivery systems and molecular purity.
- Regulatory Standing: Produced in world-class facilities certified under WHO-GMP and inspected by the US FDA and EMA, ensuring that every 5 ml unit meets the highest safety benchmarks.
- Innovation: Sun Pharma’s formulation of Winolap utilizes a specialized aqueous vehicle designed to match the natural pH and isotonicity of the eye, minimizing initial stinging upon application.
2. Composition & Active Ingredients
Each 1 ml of Winolap contains:
- Active Ingredient: Olopatadine Hydrochloride IP equivalent to Olopatadine 1 mg (0.1% w/v).
- Preservative: Benzalkonium Chloride 0.01% w/v (standard multi-dose stabilizer).
- Vehicle: Sterile isotonic aqueous base (pH balanced).
3. Mechanism of Action: How It Works
Winolap utilizes a “Dual-Path” pharmacological strategy to neutralize the ocular allergic response.
A. Selective H1 Receptor Antagonism
Olopatadine is a potent, selective antagonist of histamine H1 receptors. Upon instillation, it rapidly competes with histamine at the receptor sites on the conjunctival surface. This action immediately stops the signals that cause intense itching and prevents the vascular leakage that leads to redness and watery eyes.
B. Mast Cell Stabilization
Unlike standard antihistamines, Winolap also acts as a mast cell stabilizer. it prevents the degranulation of mast cells, thereby inhibiting the release of additional inflammatory mediators like prostaglandins and leukotrienes. This comprehensive action prevents both the “early-phase” and “late-phase” allergic reactions, providing relief for up to 8–12 hours.
4. Therapeutic Indications
Winolap 5 ml is clinically indicated for:
- Seasonal Allergic Conjunctivitis: Rapid relief of symptoms triggered by pollen, grass, and outdoor allergens.
- Perennial Allergic Conjunctivitis: Managing ocular allergies caused by year-round triggers like dust mites and pet dander.
- Ocular Redness and Swelling: Reducing the inflammatory appearance (hyperemia) of the eye associated with allergic triggers.
5. Clinical Comparison: Winolap vs. Patanol
| Feature | Winolap (Sun Pharma) | Patanol (Innovator) |
|---|---|---|
| Active Ingredient | Olopatadine 0.1% | Olopatadine 0.1% |
| Bioequivalence | **确认** | 参考品牌 |
| 止痛起效时间 | 5分钟内起效 | 5分钟内起效 |
| 给药频率 | 每日两次 | 每日两次 |
6. 给药与使用
标准给药方案
- 成人和3岁以上儿童： 每次在每只受影响的眼睛中滴入一滴，每日两次（每8至12小时一次）。
使用指南
- 彻底洗手。
- 向后倾斜头部，轻轻拉下下睑以形成小囊。
- 将滴管悬于眼睛上方，滴入一滴。**不要让滴管尖端接触眼睛或睫毛。**
- 闭眼保持2分钟，并在泪囊处轻压。
- 开封后30天内弃用，以确保无菌。
7. 注意事项与安全警告
- 戴隐形眼镜： 使用Winolap前请先取出隐形眼镜。取出后请至少等待15分钟再放回，因为防腐剂可被软性隐形眼镜吸收。
- 急性缓解： 虽然Winolap起效迅速，但并非“急救”润滑剂。如眼睛极度干燥或疼痛，请咨询专科医生。
- 副作用： 常见的局部反应包括暂时的视力模糊、干眼或轻微的“异物感”。这些症状通常在几分钟内自行消退。
8. 经过充分研究的常见问答
Q：Winolap能否长期使用？
A： 是的，Winolap在医学指导下可安全用于整个花粉季（通常为6–8周）。
Q：能否用于“结膜炎”（细菌性结膜炎）？
A： 不能。Winolap仅用于过敏性疾病，它不是抗生素，无法治疗细菌或病毒感染。
Q：使用后口中出现轻微苦味是为什么？
A： 少量药物可能通过泪道排入喉咙，这是常见且无害的现象。
9. 官方监管参考文献
- Sun Pharma 眼科指数： 官方产品数据库
- DailyMed NIH： Olopatadine Hydrochloride Ophthalmic Solution Monograph.
医疗免责声明： 本内容为基于临床药学数据的AI生成，仅用于教育目的，不构成医疗建议。如需诊断和治疗，请务必咨询持牌医疗专业人员。
评价
目前还没有评价